Growth Metrics

Pacira BioSciences (PCRX) Acquisitions (2019 - 2025)

Pacira BioSciences has reported Acquisitions over the past 2 years, most recently at $16.7 million for Q1 2025.

  • Quarterly results put Acquisitions at $16.7 million for Q1 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $16.7 million (changed N/A YoY), and the annual figure for FY2025 was $16.7 million, changed.
  • Acquisitions for Q1 2025 was $16.7 million at Pacira BioSciences, up from -$992000.0 in the prior quarter.
  • Over the last five years, Acquisitions for PCRX hit a ceiling of $16.7 million in Q1 2025 and a floor of $16.7 million in Q1 2025.